Modulation of murine macrophage function by methamphetamine

Journal of Toxicology and Environmental Health - Part A

Volumn 67, Issue 23-24, 2004, Pages 1923-1937

  In, Sang Whan ^a   Son, Eun Wha ^a   Rhee, Dong Kwon ^a   Pyo, Suhkneung ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; HYDROGEN PEROXIDE; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; METHAMPHETAMINE; NITRIC OXIDE; POLYINOSINIC POLYCYTIDYLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BODY WEIGHT; CELL ACTIVITY; CELL KILLING; CELL SECRETION; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG EFFECT; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOMODULATION; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; ANTIGENS, CD14; CENTRAL NERVOUS SYSTEM STIMULANTS; HYDROGEN PEROXIDE; MACROPHAGES; MALE; METHAMPHETAMINE; MICE; OXIDANTS; PERITONEUM;

ANIMALIA; MURINAE;

EID: 8444235044     PISSN: 15287394     EISSN: None     Source Type: Journal    
DOI: 10.1080/15287390490514589     Document Type: Conference Paper

References (34)

1. Adams, D. O., and Hamilton, T. A. 1984. The cell biology of macrophage activation. Annu. Rev. Immunol. 2:283-318.
2. Adams, D. O., and Hamilton, T. A. 1992. Molecular basis of macrophage activation: Diversity and its origins. In The macrophage, eds. C. E. Lewis, and J. O' D. McGee, pp. 77-114, New York, IRL Press.
3. Arden, L., Lansdorp, P., and De Groot, E. 1985. A growth factor for B cell hybridomas produced by human moncytes. Lymphokines 10:175-185.
4. Arenzana-Seisdedos, F., and Virelizier, J. 1983. Interferons as macrophage activating factors. II. Enhanced secretion of interleukin 1 by lipopolysaccharide-stimulated human monocytes. Eur. J. Immunol. 13:437-440.
5. Basso, A. M., Gioino, G., Molina, V. A., and Cancela, L. M. 1999. Chronic amphetamine facilitates immuno-suppression in response to a novel aversive stimulus: Reversal by haloperidol pretreatment. Pharmacol. Biochem. Behav. 62:307-314.
6. Bendtzen, K., Morling, N., Fomsgaard, A., Svenson, M., Jakobsen, B., Odum, N., and Svejgaard, A. 1988. Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand. J. Immunol. 28:599-606.
7. Briensven, F. V., Supawitkul, S., Kilmarx, P. H., Limpakarnjanarat, K., Young, N. L., Manopaiboon, C., Mock, P. A., Korattana, S., and Mastro, T. D. 2001. Rapid assessment of sexual behavior, drug use, human immunodeficiency virus, and sexually transmitted diseases in northern Thai youth using audio-computer-assisted self-interviewing and noninvasive specimen collection. Pediatrics 108:1-7.
8. Carter, K. C., Finnon, Y. S., Daeid, N. N., Robson, D. C., and Waddell, R. 2002. The effect of nitrostyrene on cell proliferation and macrophage immune responses. Immunopharmacol. Immunotoxicol. 24: 187-197.
9. Choriki, M., Freudenberg, M., Calanos, C., Poindron, P., and Bartholeyns, J. 1989. Antitumoral effects of lipopolysacchride, tumor necrosis factor, interferon and activated macrophages: Synergism and tissue distribution. Anticancer Res. 9:1185-1190.
10. Connor, T. J., McNamara M. G., Kelly, J. P., and Leonard, B. E. 1999. 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy) administration produces dose-dependent neurochemical, endocrine and immune changes in the rat. Hum. Psychopharmcol. 14:95-104.
11. Connor, T. J., Kelly, J. P., McGee, M., and Leonard, B. E. 2000. Methylendioxymethamphetmaine suppresses IL-1 beta and TNF-alpha secretion following an in vivo lipopolysaccharide challenge. Life Sci. 67:1601-1612.
12. Connor, T. J., Connelly, D. B., and Kelly, J. P. 2001. Methylendioxymethamphetmaine suppresses antigen specific IgG2a and IFN-gamma production. Immunol. Lett. 78:67-73.
13. Ding, A. H., Nathan, C. F., and Stuehr, D. J. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412.
14. Hibbs, J. B. Jr, Taintor, R. R., Vavrin, Z., and Rachlin, E. M. 1988. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157:87-94.
15. House, R. V., Thomas, P. T., and Bhargava, H. N. 1994. Comparison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines. Immunopharmacol. Immunotoxicol. 16:1-21.
16. Iwasa, M., Maeno, Y., Inoue, H., Koyama, H., and Matoba, R. 1996. Induction of apoptotic cell death in rat thymus and spleen after a bolus injection of methamphetamine. Int. J. Legal Med. 109:23-29.
17. Keller, R., Keist, R., and Frei, K. 1990. Lymphokines and bacteria that induce tumoricidal activity, trigger a different secretory response in macrophages. Eur. J. Immunol. 20:695-698.
18. Kim, K. R., Son, E. W., Um, S. H., Kim, B. O., Rhee, D. K., and Pyo, S. 2003. Immune alterations in mice exposed to the herbicide simazine. J. Toxicol. Environ. Health 66:1159-1173.
19. MacKenzie, R. G., and Heischober, B. 1997. Methamphetamine. Pediatr. Rev. 18:305-309.
20. Mavier, P., and Edgington, T. S. 1984. Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase- independent mechanism. J. Immunol. 132:1980-1984.
21. Morahan, P. S., Connor, J. R., and Leary, K. R. 1985. Viruses and the versatile macrophage. Br. Med. Bull. 410:150-210
22. Mossner, R., and Lesch, K. P. 1998. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav. Immunol. 12:249-271.
23. Nathan, C. F., and Root, R. K. 1977. Hydrogen peroxide release from mouse peritoneal macrophages: Dependence on sequential activation and triggering. J. Exp. Med. 146:1648-1662.
24. Okimura, T., Ogawa, M., and Yamauchi, T. 1986. Stress and immune responses. III. Effect of resistant stress on delayed type hypersensitivity (DTH) response, natural killer (NK) activity and phagocytosis in mice. Jpn. J. Pharmacol. 41:229-235.
25. Pyo, S., Gangemi, J. D., Ghaffar, A., and Mayer, E. P. 1991. Poly I:C-induced anti-HSV type 1 activity in inflammatory macrophages is mediated by induction of interferon-β. J. Leukocyte Biol. 50:479-487.
26. Rao, K. M. 2000. Molecular mechanisms regulating iNOS expression in various cell types. J. Toxicol. Environ. Health 63:27-58.
27. Saiki, I., and Fidler, I. J. 1984. Synergistic activation of recombinant mouse interferon-γ and muramyl dipeptide of tumoricidal properties in mouse peritoneal macrophages. J. Immunol. 135:684-688.
28. Stuehr, D. J., and Griffith, O. W. 1992. Mammalian nitric oxide synthase. Adv. Enzymol. Relat. Areas. Mol. Biol. 65:287-346.
29. Stuehr, D. J., and Marietta, M. A. 1987. Synthesis of nitrite and nitrate in macrophage cell lines. Cancer Res. 47:5590-5594.
30. Wermuth, L. 2000. Methamphetamine use: Hazards and social influences. J. Drug Educ. 30:423-433.
31. Yu, Q., Zhang, D., Walston, M., Zhang, J., Liu, Y., and Watson, R. R. 2002. Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice. Int. Immunopharmacol. 2:951-962.
32. Yu, Q., Larson, D. F., and Watson, R. R. 2003. Heart disease, methamphatamine and AIDS. Life Sci. 73:129-140.
33. Ziegler-Heitbrock, H. W. L., and Ulevitch, R. J. 1993. CD14: Cell surface receptor and differentiation marker. Immunol. Today. 14:121-125.
34. Zule, W. A., and Desmond, D. P. 1999. An ethnographic comparison of HIV risk behaviors among heroin and methamphetamine injectors. Am. J. Drug Alcohol Abuse 25:1-23.